TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Vaccinium Invest AB
Closing information (x1000 DKK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
15,918
|
29,845
|
0 |
| Financial expenses |
0
|
1
|
114 |
| Earnings before taxes |
9,153
|
3,574
|
-92 |
| EBITDA |
2,483
|
-408
|
-14 |
| Total assets |
9,064
|
6,540
|
2,856 |
| Current assets |
8,969
|
6,441
|
2,748 |
| Current liabilities |
573
|
0
|
1 |
| Equity capital |
8,491
|
6,540
|
2,855 |
| - share capital |
32
|
33
|
36 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
93.7%
|
100%
|
100.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
57.5%
|
12.0% | |
| Return on assets (ROA) |
101.0%
|
54.7%
|
0.8% |
| Current ratio | 1565.3% | 274800% | |
| Return on equity (ROE) |
107.8%
|
54.6%
|
-3.2% |
| Change turnover |
-12,854
|
29,845
|
0 |
| Change turnover % | -45% | ||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.